BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6164643)

  • 1. [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods].
    Förster H; Wicarkzyk C; Dudziak R
    Infusionsther Klin Ernahr; 1981 Apr; 8(2):88-94. PubMed ID: 6164643
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravascular persistence of hydroxyethyl starch in man.
    Boon JC; Jesch F; Ring J; Messmer K
    Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reply to W. L. Thompson's commentary (Infusionstherapie 4:56-62 1977) on G. Lindblad's and J. Falk's study on "Course of hydroxyethyl starch and dextran concentration in blood and liver of rabbits and the histopathological consequences of hydroxyethyl starch storage (Infusionstherapie 3:301-3 1976)].
    Infusionsther Klin Ernahr; 1978 Apr; 5(2):118-9. PubMed ID: 77255
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long term tolerance of highly dosed infusions of hydroxylethylstarch and dextran 60 in normovolemic rabbits].
    Hölscher B
    Infusionsther Klin Ernahr; 1975 Jun; 2(3):215-20. PubMed ID: 52620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyethyl starch: an agent for hypovolemic shock treatment.
    Mishler JM; Borberg H; Emerson PM; Gross R
    J Surg Res; 1977 Oct; 23(4):239-45. PubMed ID: 70572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anaphylactoid reaction in rats after administration of dextran and hydroxyethyl starch manufactured in Czechoslovakia (author's transl)].
    Skala E; Pospísil J; Tachecí O
    Cas Lek Cesk; 1980 Oct; 119(40-41):1098-100. PubMed ID: 6169436
    [No Abstract]   [Full Text] [Related]  

  • 7. [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].
    Köhler H; Zschiedrich H; Linfante A; Appel F; Pitz H; Clasen R
    Klin Wochenschr; 1982 Mar; 60(6):293-301. PubMed ID: 6176754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
    Schneider R; Hacke W; Kiesewetter H; Jung F
    Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch].
    Hayashi K; Higashi H
    Masui; 1975 Sep; 24(9):853-9. PubMed ID: 53296
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
    Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
    Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative investigations of hydroxyethyl starch and dextran 60 in Isovolaemic haemodilution and haemorrhagic shock of rats (author's transl)].
    Hölscher B; Edeling M; Fahrmeier G; Kagel S
    Anaesthesist; 1975 May; 24(5):215-8. PubMed ID: 56902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of low-molecular hydroxyethyl starch and dextran 60 on the muscle oxygen supply in intensive care patients].
    Kopp KH; Kieser M; Sinagowitz E; Lund N
    Infusionsther Klin Ernahr; 1982 Feb; 9(1):44-51. PubMed ID: 6176540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular persistence of hydroxyethyl starch (HES) after serial granulocyte collections using HES in man.
    Ring J; Sharkoff D; Richter W
    Vox Sang; 1980 Oct; 39(4):181-5. PubMed ID: 6163255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

  • 18. BLEEDING VOLUME INDICES OF HYDROXYETHYL STARCH, DEXTRAN, BLOOD, AND GLUCOSE.
    THOMPSON WL; WAYT DH; WALTON RP
    Proc Soc Exp Biol Med; 1964 Feb; 115():474-7. PubMed ID: 14121642
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
    Köhler H; Kirch W; Klein H; Distler A
    Anaesthesist; 1978 Sep; 27(9):421-6. PubMed ID: 82409
    [No Abstract]   [Full Text] [Related]  

  • 20. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.